PMC Articles for MedGen (Select 338164) - PMC

Links from MedGen

Items: 1 to 20 of 312

<< First< Prev

Page of 16

Select item 1973031.

Arabidopsis sfd Mutants Affect Plastidic Lipid Composition and Suppress Dwarfing, Cell Death, and the Enhanced Disease Resistance Phenotypes Resulting from the Deficiency of a Fatty Acid Desaturase

Ashis Nandi, Kartikeya Krothapalli, Christen M. Buseman, Maoyin Li, Ruth Welti, Alexander Enyedi, Jyoti Shah

Plant Cell. 2003 Oct; 15(10): 2383–2398. doi: 10.1105/tpc.015529

Correction in:: Plant Cell. 2003 Dec; 15(12): 3051.

PMCID:: PMC197303

Abstract Article PDF–3.7M

Select item 96961762.

Deglycosylation Increases the Aggregation and Angiogenic Properties of Mutant Tissue Inhibitor of Metalloproteinase 3 Protein: Implications for Sorsby Fundus Dystrophy

Jian Hua Qi, Bela Anand-Apte

Int J Mol Sci. 2022 Nov; 23(22): 14231. Published online 2022 Nov 17. doi: 10.3390/ijms232214231

PMCID:: PMC9696176

Abstract Article PDF–2.4M

Select item 96905323.

Potential CRISPR Base Editing Therapeutic Options in a Sorsby Fundus Dystrophy Patient

Maram E. A. Abdalla Elsayed, Maria Kaukonen, Peter Kiraly, Jasmina Cehajic Kapetanovic, Robert E. MacLaren

Genes (Basel) 2022 Nov; 13(11): 2103. Published online 2022 Nov 12. doi: 10.3390/genes13112103

PMCID:: PMC9690532

Abstract Article PDF–1.0M

Select item 95091194.

Sorsby fundus dystrophy (SFD): A narrative review

Georgios Tsokolas

Medicine (Baltimore) 2022 Sep 23; 101(38): e30595. Published online 2022 Sep 23. doi: 10.1097/MD.0000000000030595

PMCID:: PMC9509119

Abstract Article PDF–458K

Select item 93913845.

Treatment of Sorsby fundus dystrophy with anti-tumor necrosis factor-alpha medication

Richard F. Spaide

Eye (Lond) 2022 Sep; 36(9): 1810–1812. Published online 2021 Aug 10. doi: 10.1038/s41433-021-01735-3

PMCID:: PMC9391384

Abstract Article PDF–1.1M

Select item 44702046.

Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby’s Fundus Dystrophy

Hanae C. Y. Gourier, N. Victor Chong

J Clin Med. 2015 May; 4(5): 874–883. Published online 2015 May 4. doi: 10.3390/jcm4050874

PMCID:: PMC4470204

Abstract Article PDF–629K

Select item 46954667.

Renal replacement therapy in adult and pediatric intensive care: Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD)

Christophe Vinsonneau, Emma Allain-Launay, Clarisse Blayau, Michael Darmon, Damien du Cheyron, Theophile Gaillot, Patrick M. Honore, Etienne Javouhey, Thierry Krummel, Annie Lahoche, Serge Letacon, Matthieu Legrand, Mehran Monchi, Christophe Ridel, René Robert, Frederique Schortgen, Bertrand Souweine, Patrick Vaillant, Lionel Velly, David Osman, Ly Van Vong

Ann Intensive Care. 2015; 5: 58. Published online 2015 Dec 30. doi: 10.1186/s13613-015-0093-5

PMCID:: PMC4695466

Abstract Article PDF–1.0M

Select item 26974918.

Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy

Z. Saihan, Z. Li, J. Rice, N.A. Rana, S. Ramsden, P.G. Schlottmann, S.A. Jenkins, C. Blyth, G.C. Black, N. McKie, A.R. Webster

Mol Vis. 2009; 15: 1218–1230. Published online 2009 Jun 15.

PMCID:: PMC2697491

Abstract Article PDF–6.1M

Select item 50208639.

OCT angiography in the management of choroidal neovascular membrane secondary to Sorsby fundus dystrophy

Aditi Mohla, Kamron Khan, Melissa Kasilian, Michel Michaelides

BMJ Case Rep. 2016; 2016: bcr2016216453. Published online 2016 Sep 1. doi: 10.1136/bcr-2016-216453

PMCID:: PMC5020863

Abstract Article PDF–653K

Select item 819885410.

Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review

Arthur Baston, Christin Gerhardt, Souska Zandi, Justus G. Garweg

J Clin Med. 2021 Jun; 10(11): 2433. Published online 2021 May 30. doi: 10.3390/jcm10112433

PMCID:: PMC8198854

Abstract Article PDF–2.7M

Select item 195480111.

Matrix bound SFD mutant TIMP‐3 is more stable than wild type TIMP‐3

Mohammed A Majid, Valerie A Smith, Andrew C Newby, Andrew D Dick

Br J Ophthalmol. 2007 Aug; 91(8): 1073–1076. Published online 2007 Mar 23. doi: 10.1136/bjo.2006.113225

PMCID:: PMC1954801

Abstract Article PDF–287K

Select item 562323112.

Bilateral choroidal neovascular membrane in a young patient with Sorsby fundus dystrophy: the value of prompt treatment

Nardine Menassa, Sreekala Burgula, Theodoros Empeslidis, Konstantinos T Tsaousis

BMJ Case Rep. 2017; 2017: bcr2017220488. Published online 2017 Aug 3. doi: 10.1136/bcr-2017-220488

PMCID:: PMC5623231

Abstract Article PDF–1.1M

Select item 172382213.

Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism

M. Clarke, K. Mitchell, J. Goodship, S. McDonnell, M. Barker, I. Griffiths, N. McKie

Br J Ophthalmol. 2001 Dec; 85(12): 1429–1431. doi: 10.1136/bjo.85.12.1429

PMCID:: PMC1723822

Summary PDF–107K

Select item 172356314.

Sorsby fundus dystrophy without a mutation in the TIMP-3 gene

J. Assink, E. de Backer, B ten, T. Kohno, P. T V M de Jong, A. Bergen, F. Meire

Br J Ophthalmol. 2000 Jul; 84(7): 682–686. doi: 10.1136/bjo.84.7.682

PMCID:: PMC1723563

Summary PDF–221K

Select item 172243115.

Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa

R. Fariss, S. Apte, P. Luthert, A. Bird, A. Milam

Br J Ophthalmol. 1998 Nov; 82(11): 1329–1334. doi: 10.1136/bjo.82.11.1329

PMCID:: PMC1722431

Summary PDF–207K

Select item 1100601116.

Review: Mechanisms of TIMP-3 accumulation and pathogenesis in Sorsby fundus dystrophy

Jacob H. J. Betts, Linda Troeberg

Mol Vis. 2024; 30: 74–91. Published online 2024 Mar 3.

PMCID:: PMC11006011

Abstract Article PDF–2.3M

Select item 776775317.

The retinal pigment epithelium in Sorsby Fundus Dystrophy shows increased sensitivity to oxidative stress-induced degeneration

Alyson Wolk, Mala Upadhyay, Mariya Ali, Jason Suh, Heidi Stoehr, Vera L. Bonilha, Bela Anand-Apte

Redox Biol. 2020 Oct; 37: 101681. Published online 2020 Aug 10. doi: 10.1016/j.redox.2020.101681

PMCID:: PMC7767753

Abstract Article PDF–5.6M

Select item 659413718.

The N‐terminal p.(Ser38Cys) TIMP3 mutation underlying Sorsby fundus dystrophy is a founder mutation disrupting an intramolecular disulfide bond

Sarah Naessens, Julie De Zaeytijd, Delfien Syx, Roosmarijn E. Vandenbroucke, Frédéric Smeets, Caroline Van Cauwenbergh, Bart P. Leroy, Frank Peelman, Frauke Coppieters

Hum Mutat. 2019 May; 40(5): 539–551. Published online 2019 Feb 6. doi: 10.1002/humu.23713

PMCID:: PMC6594137

Abstract Article PDF–611K

Select item 103969519.

Sorsby's pseudoinflammatory macular dystrophy.

A. Hoskin, K. Sehmi, A. C. Bird

Br J Ophthalmol. 1981 Dec; 65(12): 859–865. doi: 10.1136/bjo.65.12.859

PMCID:: PMC1039695

Summary Page Browse PDF–3.3M

Select item 687452920.

Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism

Jian Hua Qi, Brent Bell, Rupesh Singh, Julia Batoki, Alyson Wolk, Alecia Cutler, Nicholas Prayson, Mariya Ali, Heidi Stoehr, Bela Anand-Apte

Sci Rep. 2019; 9: 17429. Published online 2019 Nov 22. doi: 10.1038/s41598-019-53433-6

PMCID:: PMC6874529

Abstract Article PDF–4.7M

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 312

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity